While these results are not directly translatable to human subjects, the observed reduction in mean tissue loss severity and overall incidence of severe gangrene in this study demonstrates promise for local E-selectin-based gene therapy as a potential treatment for limb-threatening ischemia. The gene discussed is SELE; the disease is ischemia.